Departments & Divisions
Dr. Suryavathi Viswanadhapalli received her Doctorate in Reproductive Toxicology from the University of Rajasthan, India in 2007. She completed her first postdoctoral fellowship at the University of Virginia focusing on the genetic causes of infertility and endocrine disorders. In addition to this, she completed a second postdoctoral fellowship at UT Health specializing in hormonal carcinogenesis; therapy resistance; and drug development using endometrial, breast, and ovarian cancer models. In 2018, she was appointed as a Research Instructor in the Department of Obstetrics and Gynecology at UT Health San Antonio. Currently, Dr. Viswanadhapalli’s research is focused on the development, characterization, and validation of new therapies for women’s cancers. Her current research interests include developing small molecules targeting novel oncogenes, establishing the mechanism of action of new drugs, using CRISPR/Cas9 screens, studying mechanisms of therapy resistance, and developing preclinical models of cancer progression including xenografts (patient derived explant [PDeX] and patient derived Xenograft [PDX]).